Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aveo defends kidney cancer drug rejected by the FDA
Aveo defends kidney cancer drug rejected by the FDA
Aveo defends kidney cancer drug rejected by the FDA
Submitted by
admin
on June 12, 2013 - 9:15am
Source:
Boston Globe, MA
News Tags:
kidney cancer
FDA
Aveo Oncology
tivozanib
Headline:
Aveo defends kidney cancer drug rejected by the FDA
Do Not Allow Advertisers to Use My Personal information